 VICTORIA, British Columbia--BUSINESS WIRE--- IPA Deltavariant--IMMUNOPRECISE ANTIBODIES LTD. the Company or IPA NASDAQ: IPA TSX VENTURE: IPA, a leader in full-service therapeutic antibody discovery and development, today announced that it has entered into an At-The-Market Distribution Agreement the ATM Agreement with H.C. Wainwright Co., LLC, as sole sales agent the Agent. Under the ATM Agreement, the Company will be entitled, at its discretion and from time-to-time during the term of the 